Supernus Pharmaceuticals Inc.

01/27/2025 | Press release | Distributed by Public on 01/27/2025 07:00

Supernus Announces Label Update for Non-Stimulant ADHD Treatment, Qelbree®, Including New Pharmacodynamic Data and Information for Breastfeeding Women

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.